- Report
- August 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,443GBP
€3653EUR$3,950USD£3,053GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,054USD£3,028GBP
- Report
- November 2021
- 65 Pages
Europe
From €1387EUR$1,500USD£1,160GBP
- Report
- June 2026
- 144 Pages
South Korea
From €2266EUR$2,450USD£1,894GBP
- Report
- April 2024
- 178 Pages
Global
From €4116EUR$4,450USD£3,440GBP
- Report
- January 2023
- 154 Pages
Africa, Middle East
From €3191EUR$3,450USD£2,667GBP
- Report
- January 2023
- 161 Pages
Europe
From €3191EUR$3,450USD£2,667GBP
- Report
- January 2023
- 170 Pages
Asia Pacific
From €3191EUR$3,450USD£2,667GBP
- Report
- September 2022
- 240 Pages
Global
From €4116EUR$4,450USD£3,440GBP
- Report
- June 2025
- 130 Pages
Global
From €4486EUR$4,850USD£3,749GBP
- Report
- March 2024
- 122 Pages
Asia Pacific
From €1387EUR$1,500USD£1,160GBP
- Report
- March 2024
- 110 Pages
North America
From €1387EUR$1,500USD£1,160GBP
- Report
- May 2026
- 213 Pages
Canada
From €4486EUR$4,850USD£3,749GBP
- Report
- May 2026
- 215 Pages
India
From €4486EUR$4,850USD£3,749GBP
- Report
- May 2026
- 219 Pages
Malaysia
From €4486EUR$4,850USD£3,749GBP
- Report
- January 2026
- 150 Pages
Japan
From €4486EUR$4,850USD£3,749GBP
- Report
- January 2026
- 150 Pages
Japan
From €4486EUR$4,850USD£3,749GBP

Psoriasis is a chronic skin condition that affects millions of people worldwide. It is characterized by red, scaly patches on the skin that can be itchy and painful. It is caused by an overactive immune system that triggers inflammation and rapid skin cell growth. Treatment for psoriasis typically involves topical medications, phototherapy, and systemic medications.
The psoriasis market is a subset of the larger dermatology market. It is a rapidly growing market, driven by the increasing prevalence of psoriasis and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for psoriasis.
Some of the major companies in the psoriasis market include AbbVie, Amgen, Celgene, Janssen, Novartis, Pfizer, and UCB. These companies offer a range of treatments, including topical medications, phototherapy, and systemic medications. Show Less Read more